Oncology Precision Medicine Market 规模与份额分析 - 成长趋势与预测 (2024 - 2031)

Oncology Precision Medicine Market is segmented By Type of Cancer (Bladder Cancer, Blood / Hematologic Cancer, Breast Cancer, Cervical Cancer, Gastrointestinal Cancer, Head and Neck Squamous Cell Cancer, Lung Cancer, Skin Cancer, Others), By Route of Administration (Oral, Intravenous, Others), By Type of Molecule (Small Molecules, Biologics), By Drug Class (Kinase Inhibitors, Enzyme Inhibitors, Immune Checkpoint Inhibitors, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Oncology Precision Medicine Market Leaders

  • 阿斯特拉泽内卡
  • 诺华
  • 辉瑞
  • 布里斯托尔-迈尔斯·斯基布
  • 罗什
*Disclaimer: Major players are listed in no particular order.

Oncology Precision Medicine Market - Company List

  • 阿斯特拉泽内卡
  • 诺华
  • 辉瑞
  • 布里斯托尔-迈尔斯·斯基布
  • 罗什
  • 阿门
  • 生物NTech( 生物NTech)
  • 基列科学
  • Merck & Co. (美国英语).
  • 光明日报社
  • 基础医学
  • 卫士保健
  • 卡里斯生命科学
  • 精确科学
  • 迈里亚德遗传学
  • 瑟莫·费舍尔科学
  • 受难者
  • 基因组保健
  • 摇摆
  • 腾讯